Alexandria Real Estate Equities (NYSE:ARE) Releases FY 2025 Earnings Guidance

Alexandria Real Estate Equities (NYSE:ARE) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 9.230-9.430 for the period, compared to the consensus estimate of 9.470. The company issued revenue guidance of -.

Alexandria Real Estate Equities Trading Down 4.8 %

Shares of ARE opened at $97.19 on Wednesday. Alexandria Real Estate Equities has a fifty-two week low of $94.35 and a fifty-two week high of $130.14. The company has a market capitalization of $16.98 billion, a PE ratio of 59.26, a price-to-earnings-growth ratio of 3.85 and a beta of 1.16. The stock has a fifty day moving average of $102.07 and a two-hundred day moving average of $112.07. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.20 and a current ratio of 0.20.

Alexandria Real Estate Equities (NYSE:ARE) last announced its quarterly earnings data on Monday, January 27th. The real estate investment trust reported $2.39 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $1.48. Alexandria Real Estate Equities had a return on equity of 1.31% and a net margin of 9.62%. As a group, analysts forecast that Alexandria Real Estate Equities will post 9.47 EPS for the current year.

Alexandria Real Estate Equities Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were issued a dividend of $1.32 per share. This is a positive change from Alexandria Real Estate Equities’s previous quarterly dividend of $1.30. This represents a $5.28 annualized dividend and a dividend yield of 5.43%. The ex-dividend date of this dividend was Tuesday, December 31st. Alexandria Real Estate Equities’s dividend payout ratio is presently 321.95%.

Alexandria Real Estate Equities announced that its board has initiated a share repurchase plan on Monday, December 9th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the real estate investment trust to repurchase up to 2.7% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Evercore ISI cut their price target on shares of Alexandria Real Estate Equities from $129.00 to $124.00 and set an “in-line” rating on the stock in a research note on Wednesday, October 23rd. Robert W. Baird reduced their target price on Alexandria Real Estate Equities from $137.00 to $130.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Deutsche Bank Aktiengesellschaft lowered Alexandria Real Estate Equities from a “buy” rating to a “hold” rating and dropped their price target for the stock from $135.00 to $112.00 in a research note on Friday, November 15th. JPMorgan Chase & Co. lowered Alexandria Real Estate Equities from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $133.00 to $121.00 in a research note on Wednesday, November 27th. Finally, JMP Securities decreased their target price on Alexandria Real Estate Equities from $140.00 to $130.00 and set a “market outperform” rating for the company in a report on Friday, November 15th. Nine research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $121.90.

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.